Poulvac E. coli Eiropas Savienība - latviešu - EMA (European Medicines Agency)

poulvac e. coli

zoetis belgium sa - dzīvot aroa gēnu svītrots escherichia coli, tipa 078, celms ec34195 - immunologicals par aves, dzīvu baktēriju vakcīnas - chicken; turkeys - aktīvās imunizācijas broileru vistas un nākotnes slāņi / audzētājiem, lai samazinātu mirstību un bojājumi (perikardīts, perihepatitis, airsacculitis), kas saistīti ar escherichia coli serotips o78.

H-500 (Paziņots 2012.) kapsula Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

h-500 (paziņots 2012.) kapsula

bio international inc. pēc coral club international inc. (kanāda) pasūtījuma - kapsula

Vidaza Eiropas Savienība - latviešu - EMA (European Medicines Agency)

vidaza

bristol-myers squibb pharma eeig - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiski līdzekļi - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.

Azacitidine Celgene Eiropas Savienība - latviešu - EMA (European Medicines Agency)

azacitidine celgene

celgene europe bv - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiski līdzekļi - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

Lecithin (Paziņots 2010.) kapsula Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

lecithin (paziņots 2010.) kapsula

united pharma llc., 2317 moore avenue., fullerton, ca 92833(asv) ekskluzīvi pēc coral club international, inc., 255 duncan mill - kapsula